Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 35% ± 15% | |
peripheral blood | 14 studies | 35% ± 13% | |
intestine | 11 studies | 29% ± 12% | |
brain | 10 studies | 27% ± 10% | |
kidney | 8 studies | 27% ± 8% | |
eye | 8 studies | 27% ± 9% | |
liver | 6 studies | 35% ± 22% | |
lymph node | 6 studies | 38% ± 13% | |
bone marrow | 5 studies | 33% ± 9% | |
uterus | 4 studies | 32% ± 15% | |
breast | 4 studies | 25% ± 7% | |
thymus | 3 studies | 58% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9568.20 | 2642 / 2642 | 100% | 150.53 | 705 / 705 |
breast | 100% | 5362.70 | 459 / 459 | 100% | 99.36 | 1118 / 1118 |
esophagus | 100% | 6783.03 | 1445 / 1445 | 100% | 89.51 | 183 / 183 |
lung | 100% | 6346.22 | 578 / 578 | 100% | 84.29 | 1155 / 1155 |
ovary | 100% | 5870.48 | 180 / 180 | 100% | 68.91 | 430 / 430 |
prostate | 100% | 6159.80 | 245 / 245 | 100% | 81.01 | 502 / 502 |
stomach | 100% | 5279.05 | 359 / 359 | 100% | 81.82 | 286 / 286 |
uterus | 100% | 7302.62 | 170 / 170 | 100% | 100.15 | 459 / 459 |
thymus | 100% | 6371.54 | 653 / 653 | 100% | 81.32 | 604 / 605 |
intestine | 100% | 8455.56 | 966 / 966 | 100% | 81.70 | 526 / 527 |
bladder | 100% | 6268.24 | 21 / 21 | 100% | 76.89 | 502 / 504 |
kidney | 100% | 5719.01 | 89 / 89 | 100% | 75.03 | 897 / 901 |
liver | 100% | 3211.25 | 226 / 226 | 99% | 49.06 | 403 / 406 |
skin | 100% | 4889.89 | 1807 / 1809 | 99% | 86.39 | 468 / 472 |
adrenal gland | 100% | 5332.21 | 258 / 258 | 99% | 64.16 | 227 / 230 |
pancreas | 98% | 2813.65 | 323 / 328 | 99% | 62.19 | 176 / 178 |
adipose | 100% | 5261.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7759.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.93 | 29 / 29 |
muscle | 100% | 8397.93 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5404.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 102.45 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.03 | 1 / 1 |
heart | 99% | 6628.76 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 4182.56 | 888 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 35.92 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0008150 | Biological process | biological_process |
GO_0031507 | Biological process | heterochromatin formation |
GO_0070062 | Cellular component | extracellular exosome |
GO_0000786 | Cellular component | nucleosome |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0030527 | Molecular function | structural constituent of chromatin |
GO_0003674 | Molecular function | molecular_function |
Gene name | H2AZ2 |
Protein name | Histone H2A Histone H2A.V (H2A.F/Z) (H2A.Z variant histone 2) H2A.Z variant histone 2 |
Synonyms | H2AV H2AFV |
Description | FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in the formation of constitutive heterochromatin. May be required for chromosome segregation during cell division (By similarity). . |
Accessions | Q71UI9 ENST00000437072.5 ENST00000350771.7 [Q71UI9-4] ENST00000521529.5 ENST00000349299.7 [Q71UI9-3] ENST00000308153.9 [Q71UI9-1] E5RJU1 ENST00000222690.10 [Q71UI9-2] C9J0D1 ENST00000446531.1 C9J386 ENST00000381124.9 [Q71UI9-5] |